The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 17 Oct 2006
doi: 10.1242/jcs.03218
Research Article
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition
Ester Martín-Villar,
Diego Megías,
Susanna Castel,
Maria Marta Yurrita,
Senén Vilaró,
and
Miguel Quintanilla*
* Author for correspondence (e-mail: mquintanilla{at}iib.uam.es)
Podoplanin is a small membrane mucin expressed in tumors associated with malignant progression. It is enriched at cell-surface protrusions where it colocalizes with members of the ERM (ezrin, radixin, moesin) protein family. Here, we found that human podoplanin directly interacts with ezrin (and moesin) in vitro and in vivo through a cluster of basic amino acids within its cytoplasmic tail, mainly through a juxtamembrane dipeptide RK. Podoplanin induced an epithelial-mesenchymal transition in MDCK cells linked to the activation of RhoA and increased cell migration and invasiveness. Fluorescence time-lapse video observations in migrating cells indicate that podoplanin might be involved in ruffling activity as well as in retractive processes. By using mutant podoplanin constructs fused to green fluorescent protein we show that association of the cytoplasmic tail with ERM proteins is required for upregulation of RhoA activity and epithelial-mesenchymal transition. Furthermore, expression of either a dominant-negative truncated variant of ezrin or a dominant-negative mutant form of RhoA blocked podoplanin-induced RhoA activation and epithelial-mesenchymal transition. These results provide a mechanistic basis to understand the role of podoplanin in cell migration or invasiveness.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
H M Kocher, J Sandle, T A Mirza, N F Li, and I R Hart
Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells
Gut,
February 1, 2009;
58(2):
271 - 284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Navarro, R. E. Perez, M. Rezaiekhaligh, S. M. Mabry, and I. I. Ekekezie
T1{alpha}/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells
Am J Physiol Lung Cell Mol Physiol,
October 1, 2008;
295(4):
L543 - L551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. Vanderbilt, L. Allen, R. F. Gonzalez, Z. Tigue, J. Edmondson, D. Ansaldi, A. M. Gillespie, and L. G. Dobbs
Directed Expression of Transgenes to Alveolar Type I Cells in the Mouse
Am. J. Respir. Cell Mol. Biol.,
September 1, 2008;
39(3):
253 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Alcorn, A. S. Guala, J. van der Velden, B. McElhinney, C. G. Irvin, R. J. Davis, and Y. M. W. Janssen-Heininger
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-{beta}1
J. Cell Sci.,
April 1, 2008;
121(7):
1036 - 1045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. T. IJpelaar, A. Schulz, K. Koop, M. Schlesener, J. A. Bruijn, D. Kerjaschki, R. Kreutz, and E. de Heer
Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Fromter rats
Am J Physiol Renal Physiol,
April 1, 2008;
294(4):
F758 - F767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Fischer, C. H. Cunliffe, R. J. Bollo, S. Raza, D. Monoky, L. Chiriboga, E. C. Parker, J. G. Golfinos, P. J. Kelly, E. A. Knopp, et al.
High-grade glioma before and after treatment with radiation and Avastin: Initial observations
Neuro-oncol,
January 1, 2008;
10(5):
700 - 708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Perez-Gomez, M. Villa-Morales, J. Santos, J. Fernandez-Piqueras, C. Gamallo, J. Dotor, C. Bernabeu, and M. Quintanilla
A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
Cancer Res.,
November 1, 2007;
67(21):
10268 - 10277.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
